Pharma Surge

Pharma Surge

🇺🇸·6d agoIndustry

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

2025 Second-Quarter reported sales growth of 5.8% to $23.7 Billion with operational growth of 4.6%*...

Publisher

J
Johnson & Johnson News

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Johnson & Johnson News
Region
USA
Scope
Industry
Published
July 15, 2026
Language
EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

2025 Second-Quarter reported sales growth of 5.8% to $23.7 Billion with operational growth of 4.6%*...

Source route

Continue on jnj.com

Leave the platform to read the original full article on the publisher site.

Source: Johnson & Johnson News

Scope: Industry

Open original article
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook | Pharma Surge